STMN1 and nasopharyngeal carcinoma: Again similarly, Wu and colleagues determined that combination paclitaxel and siRNA-mediated STMN1 silencing increased to tending of apoptosis in nasopharynx carcinoma cell lines (Wu et al., 2014).